Pangenome Analysis Reveals Novel Contact-Dependent Growth Inhibition System and Phenazine Biosynthesis Operons in Proteus mirabilis BL95 That Are Located in An Integrative and Conjugative Element.

Proteus mirabilis is a leading cause of urinary tract infections and a common commensal of the gastrointestinal tract. Our recent study (JB) showed that P. mirabilis strain BL95 employs a novel contact-dependent killing system against enteric bacteria in the mouse gut and in vitro. To uncover the genetic determinants of this system, we performed whole-genome sequencing of BL95 and compared it with 98 complete genomes of P. mirabilis. BL95 carries 56 coding sequences (CDSs) not found in other P. mirabilis. Over half of these unique genes are located on a novel integrative conjugative element (ICE) named ICEPm2, inserted in tRNA-Phe and exclusive to BL95. ICEPm2 has integration, conjugation, and DNA replication modules nearly identical to ICEPm1 (common in P. mirabilis), but ICEPm2 of BL95 carries two unique operons for P. mirabilis-a phenazine biosynthesis and a contact-dependent growth inhibition (CDI) system. ICEPm2 is absent in the P. mirabilis (AR_0156) closest to BL95 and it is present in the genomes of several Escherichia coli from mouse intestines, indicating its recent horizontal mobilization. BL95 shares over 100 genes of five different secretion systems with other P. mirabilis, mostly poorly studied, making a large pool of candidate genes for the contact-dependent growth inhibition.

Legionella maintains host cell ubiquitin homeostasis by effectors with unique catalytic mechanisms.

The reversal of ubiquitination induced by members of the SidE effector family of Legionella pneumophila produces phosphoribosyl ubiquitin (PR-Ub) that is potentially detrimental to host cells. Here we show that the effector LnaB functions to transfer the AMP moiety from ATP to the phosphoryl moiety of PR-Ub to convert it into ADP-ribosylated ubiquitin (ADPR-Ub), which is further processed to ADP-ribose and functional ubiquitin by the (ADP-ribosyl)hydrolase MavL, thus maintaining ubiquitin homeostasis in infected cells. Upon being activated by Actin, LnaB also undergoes self-AMPylation on tyrosine residues. The activity of LnaB requires a motif consisting of Ser, His and Glu (S-HxxxE) present in a large family of toxins from diverse bacterial pathogens. Our study not only reveals intricate mechanisms for a pathogen to maintain ubiquitin homeostasis but also identifies a new family of enzymes capable of protein AMPylation, suggesting that this posttranslational modification is widely used in signaling during host-pathogen interactions.

LL37 Microspheres Loaded on Activated Carbon-chitosan Hydrogel: Anti-bacterial and Anti-toxin Wound Dressing for Chronic Wound Infections.

Antimicrobial peptide LL37 is a promising antibacterial candidate due to its potent antimicrobial activity with no known bacterial resistance. However, intrinsically LL37 is susceptible to degradation in wound fluids limits its effectiveness. Bacterial toxins which are released after cell lysis are found to hinder wound healing. To address these challenges, encapsulating LL37 in microspheres (MS) and loading the MS onto activated carbon (AC)-chitosan (CS) hydrogel. This advanced wound dressing not only protects LL37 from degradation but also targets bacterial toxins, aiding in the healing of chronic wound infections. First, LL37 MS and LL37-AC-CS hydrogel were prepared and characterised in terms of physicochemical properties, drug release, and peptide-polymer compatibility. Antibacterial and antibiofilm activity, bacterial toxin elimination, cell migration, and cell cytotoxicity activities were investigated. LL37-AC-CS hydrogel was effective against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. LL37-AC-CS hydrogel bound more endotoxin than AC with CS hydrogel alone. The hydrogel also induced cell migration after 72 h and showed no cytotoxicity towards NHDF after 72 h of treatment. In conclusion, the LL37-AC-CS hydrogel was shown to be a stable, non-toxic advanced wound dressing method with enhanced antimicrobial and antitoxin activity, and it can potentially be applied to chronic wound infections to accelerate wound healing.

Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection.

Clostridioides difficile infection (CDI) is the leading cause of nosocomial antibiotic-associated diarrhea, and colitis, with increasing incidence and healthcare costs. Its pathogenesis is primarily driven by toxins produced by the bacterium C. difficile, Toxin A (TcdA) and Toxin B (TcdB). Certain strains produce an additional toxin, the C. difficile transferase (CDT), which further enhances the virulence and pathogenicity of C. difficile. These toxins disrupt colonic epithelial barrier integrity, and induce inflammation and cellular damage, leading to CDI symptoms. Significant progress has been made in the past decade in elucidating the molecular mechanisms of TcdA, TcdB, and CDT, which provide insights into the management of CDI and the future development of novel treatment strategies based on anti-toxin therapies. While antibiotics are common treatments, high recurrence rates necessitate alternative therapies. Bezlotoxumab, targeting TcdB, is the only available anti-toxin, yet limitations persist, prompting ongoing research. This review highlights the current knowledge of the structure and mechanism of action of C. difficile toxins and their role in disease. By comprehensively describing the toxin-mediated mechanisms, this review provides insights for the future development of novel treatment strategies and the management of CDI.

New insight into mycotoxins and bacterial toxins: Toxicity assessment, molecular mechanism and food safety (preface to the special issue of food and chemical toxicology on the outcomes of Myco & bacterial toxin).

The special issue "New Insight into Mycotoxins and Bacterial Toxins: Toxicity Assessment, Molecular Mechanism and Food Safety" in Food and Chemical Toxicology contains 19 articles on current hot topics in mycotoxins and bacterial toxins. Dietary exposure to mycotoxins and risk assessments are reported in this issue. Molecular mechanisms of multiple mycotoxins and emerging mechanisms of toxicity are especially concerned by researchers. Moreover, mycotoxin-detoxifying substances and antimicrobial agents are also fully investigated in the context. This special issue will help to further understand the mycotoxins and bacterial toxins, casting new light for the control of food safety.

Bacterial Proteins and Peptides as Potential Anticancer Agents: A Novel Search for Protein-based Therapeutics.

Tumor diseases remain among the world's primary causes of death despite substantial advances in cancer diagnosis and treatment. The adverse chemotherapy problems and sensitivity towards drugs for some cancer types are among the most promising challenges in modern treatment. Finding new anti-cancer agents and drugs is, therefore, essential. A significant class of biologically active substances and prospective medications against cancer is comprised of bacterial proteins and peptides. Among these bacterial peptides, some of them, such as anti-cancer antibiotics and many toxins like diphtheria are widely being used in the treatment of cancer. In contrast, the remaining bacterial peptides are either in clinical trials or under research in vitro studies. This study includes the most recent information on the characteristics and mechanism of action of the bacterial peptides that have anti-cancer activities, some of which are now being employed in cancer therapy while some are still undergoing research.

An Updated View on the Cellular Uptake and Mode-of-Action of Clostridioides difficile Toxins.

Research on the human gut pathogen Clostridioides (C.) difficile and its toxins continues to attract much attention as a consequence of the threat to human health posed by hypervirulent strains. Toxin A (TcdA) and Toxin B (TcdB) are the two major virulence determinants of C. difficile. Both are single-chain proteins with a similar multidomain architecture. Certain hypervirulent C. difficile strains also produce a third toxin, namely binary toxin CDT (C. difficile transferase). C. difficile toxins are the causative agents of C. difficile-associated diseases (CDADs), such as antibiotics-associated diarrhea and pseudomembranous colitis. For that reason, considerable efforts have been expended to unravel their molecular mode-of-action and the cellular mechanisms responsible for their uptake. Many of these studies have been conducted in European laboratories. Here, we provide an update on our previous review (Papatheodorou et al. Adv Exp Med Biol, 2018) on important advances in C. difficile toxins research.

Structure of a tripartite protein complex that targets toxins to the type VII secretion system.

Type VII secretion systems are membrane-embedded nanomachines used by Gram-positive bacteria to export effector proteins from the cytoplasm to the extracellular environment. Many of these effectors are polymorphic toxins comprised of an N-terminal Leu-x-Gly (LXG) domain of unknown function and a C-terminal toxin domain that inhibits the growth of bacterial competitors. In recent work, it was shown that LXG effectors require two cognate Lap proteins for T7SS-dependent export. Here, we present the 2.6 Å structure of the LXG domain of the TelA toxin from the opportunistic pathogen Streptococcus intermedius in complex with both of its cognate Lap targeting factors. The structure reveals an elongated α-helical bundle within which each Lap protein makes extensive hydrophobic contacts with either end of the LXG domain. Remarkably, despite low overall sequence identity, we identify striking structural similarity between our LXG complex and PE-PPE heterodimers exported by the distantly related ESX type VII secretion systems of Mycobacteria implying a conserved mechanism of effector export among diverse Gram-positive bacteria. Overall, our findings demonstrate that LXG domains, in conjunction with their cognate Lap targeting factors, represent a tripartite secretion signal for a widespread family of T7SS toxins.

Toxinome-the bacterial protein toxin database.

IMPORTANCE: Microbes use protein toxins as important tools to attack neighboring cells, microbial or eukaryotic, and for self-killing when attacked by viruses. These toxins work through different mechanisms to inhibit cell growth or kill cells. Microbes also use antitoxin proteins to neutralize the toxin activities. Here, we developed a comprehensive database called Toxinome of nearly two million toxins and antitoxins that are encoded in 59,475 bacterial genomes. We described the distribution of bacterial toxins and identified that they are depleted by bacteria that live in hot and cold temperatures. We found 5,161 cases in which toxins and antitoxins are densely clustered in bacterial genomes and termed these areas "Toxin Islands." The Toxinome database is a useful resource for anyone interested in toxin biology and evolution, and it can guide the discovery of new toxins.

Influência da ativação ultrassônica do gel de hipoclorito de sódio 3 por cento, e da medicação intracanal com hidróxido de cálcio sobre micro-organismos e ácido lipoteicóico / Influence of activation by ultrasound on sodium hypochlorite 3% gel and an intracanal medication of calcium hydroxide on microrganisms and lipotheicoic acid

O objetivo deste estudo foi avaliar in vitro a ação do gel de hipoclorito de sódio (NaOCl) 3 % e da medicação intracanal (MIC) de hidróxido de cálcio (CaOH2), agitados ou não por ultrassom sobre Enterococcus faecalis, Escherichia coli e ácido lipoteicóico (LTA). Para isso 80 dentes humanos unirradiculares tiveram suas coroas removidas padronizando seu comprimento em 16 mm +- 0,5 mm, sendo seus canais instrumentados inicialmente até instrumento R25 (Reciproc). Os canais foram contaminados com suspensões de E. faecalis e E. coli. Os canais foram instrumentados utilizando-se instrumento R40, sob irrigação com 2 ml de NaOCl 3% gel seguida de irrigação com 10 ml de solução salina estéril e apirogênica. Após os canais foram irrigados com EDTA 17%, seguido de irrigação com 5 ml de solução salina estéril e apirogênica, sendo por último preenchidos com medicação intracanal de hidróxido de cálcio mantida durante 7 ou 14 dias. Os espécimes foram divididos inicialmente em 2 grupos (n=40) de acordo com a agitação ultrassônica (US) ou não da substância química auxiliar. Sendo novamente divididos de acordo com a agitação ultrassônica ou não da medicação intracanal (MIC) e o tempo de ação desta (n=10): 1) NaOCl + Ca(OH)2 (7 dias). 2) NaOCl + Ca(OH)2 (14 dias). 3) NaOCl + Ca(OH)2 com US (7 dias) 4) NaOCl + Ca(OH)2 com US (14 dias). 5) NaOCl com US + Ca(OH)2 (7 dias). 6) NaOCl com US + Ca(OH)2 (14dias) 7) NaOCl com US + Ca(OH)2 com US (7dias). 8) NaOCl com US + Ca(OH)2 com US (14 dias). Foram realizadas coletas do canal radicular 28 dias após o início da contaminação dos espécimes (1ª coleta), logo após o preparo biomecânico (PBM) (2ª coleta), logo após o preenchimento com EDTA (3ª coleta) e após o tempo de ação da MIC (4ª coleta). Para todas as coletas foram avaliadas a atividade antimicrobiana (UFC/ml) e quantificação de LTA pelo teste de Elisa. Os resultados foram submetidos aos testes estatísticos Kruskal-Wallis e Dunn (5%). Verificou-se pela análise microbiana e quantificação de LTA, que o NaOCl 3% gel foi capaz de eliminar quase completamente os micro-organismos dos canais radiculares, mas não o ácido lipoteicóico, independente da ativação ultrassônica. A ativação da MIC de Ca(OH)2 não exerceu efeito sobre micro-organismos. Sobre LTA, a ativação da MIC de Ca(OH)2 não foi eficaz, sendo os grupos com maior percentual de redução os que não sofreram agitação da MIC, nem do NaOCl. Conclui-se que o NaOCl 3% gel boa tem capacidade antimicrobina, independente da ativação ultrassônica. O PBM não foi capaz de detoxificar o LTA dos canais radiculares. A MIC com ativação ultrassônica não foi eficiente na redução de LTA(AU)

The aim of this study was to evaluate in vitro the action of sodium hypochlorite (NaOCl) 3% gel and calcium hydroxide as an intracanal medication, both activated by ultrasound on the reduction of E. faecalis e E. coli and lipotheicoic acid (LTA). Eight human single-rooted teeth with standardized size of 16 mm were prepared initially to R25 instrument (Reciproc) and distributed in microplate (n = 10). After sterilization (Co60 gamma radiation), the infection was carried out 8 microlitres of E. coli suspension, and after 7 days 8 microlitres of E. faecalis suspension, maintained for 21 days. Following the collection confirmation was performed (1st collection), then the root were instrumented using R40 instrument, irrigation with 2 ml of NaOCl 3% gel followed by washing with 10 ml of saline. The specimens were divided into 8 groups (n = 10) according to different ultrasonic irrigation protocols and different periods exposed to intracanal medication: 1) NaOCl + Ca(OH)2(7 days). 2) NaOCl + Ca(OH)2 (14 days). 3) NaOCl + Ca(OH)2 with PUI (7 dias) 4) NaOCl + Ca(OH)2 with PUI (14 days). 5) NaOCl with PUI + Ca(OH)2 (7 days). 6) NaOCl with PUI + Ca(OH)2 (14 days) 7) NaOCl with PUI + Ca(OH)2 (7 days). 8) NaOCl with PUI + Ca(OH)2 with PUI (14 days). Were made to sample colections of content of root canals, after instrumentation (2nd sample), after the use of EDTA (3rd sample) and after the Ca(OH)2 (4th Collection) . Microbiological culture and LTA quantification revealed that 3 % NaOCl gel was capable to eliminate E. faecalis and E. coli almost completely from root canals, but not lipotheicoic acid, regardless the use of ultrasonic activation. The ultrasonic activation of intracanal medication (Ca(OH)2) was not effective in removing neither microorganisms nor LTA. In addition, the groups with greatest reduction were the ones with no ultrasonic activation either of intracanal medication or NaOCl. It was concluded that 3% NaOCl gel is effective on antimicrobial activity regardless the use of ultrasonic activation. Biomechanical preparation was not capable to detoxify LTA from root canals. Ultrasonic activation of intracanal medication was not effetive on LTA reduction(AU)

Staphylococcal superantigen-specific IgE antibodies: degree of sensitization and association with severity of asthma / Anticorpos IgE específicos para superantígenos estafilocócicos: grau de sensibilização e associação com a gravidade da asma

ABSTRACT Objective: To determine the presence of staphylococcal superantigen-specific IgE antibodies and degree of IgE-mediated sensitization, as well as whether or not those are associated with the severity of asthma in adult patients. Methods: This was a cross-sectional study involving outpatients with asthma under treatment at a tertiary care university hospital in the city of Rio de Janeiro, Brazil. Consecutive patients were divided into two groups according to the severity of asthma based on the Global Initiative for Asthma criteria: mild asthma (MA), comprising patients with mild intermittent or persistent asthma; and moderate or severe asthma (MSA). We determined the serum levels of staphylococcal toxin-specific IgE antibodies, comparing the results and performing a statistical analysis. Results: The study included 142 patients: 72 in the MA group (median age = 46 years; 59 females) and 70 in the MSA group (median age = 56 years; 60 females). In the sample as a whole, 62 patients (43.7%) presented positive results for staphylococcal toxin-specific IgE antibodies: staphylococcal enterotoxin A (SEA), in 29 (20.4%); SEB, in 35 (24.6%); SEC, in 33 (23.2%); and toxic shock syndrome toxin (TSST), in 45 (31.7%). The mean serum levels of IgE antibodies to SEA, SEB, SEC, and TSST were 0.96 U/L, 1.09 U/L, 1.21 U/L, and 1.18 U/L, respectively. There were no statistically significant differences between the two groups in terms of the qualitative or quantitative results. Conclusions: Serum IgE antibodies to SEA, SEB, SEC, and TSST were detected in 43.7% of the patients in our sample. However, neither the qualitative nor quantitative results showed a statistically significant association with the clinical severity of asthma.

RESUMO Objetivo: Determinar a presença de anticorpos IgE específicos para superantígenos estafilocócicos e o grau de sensibilização mediada por esses, assim como se esses estão associados à gravidade da asma em pacientes adultos. Métodos: Estudo transversal incluindo asmáticos adultos em acompanhamento ambulatorial em um hospital universitário terciário no Rio de Janeiro (RJ). Os pacientes foram alocados consecutivamente em dois grupos de gravidade da asma segundo critérios da Global Initiative for Asthma: asma leve (AL), com asmáticos leves intermitentes ou persistentes, e asma moderada ou grave (AMG). Foram determinados os níveis séricos de anticorpos IgE antitoxinas estafilocócicas, e os resultados foram comparados por análise estatística. Resultados: Foram incluídos 142 pacientes no estudo: 72 no grupo AL (mediana de idade = 46 anos; 59 do sexo feminino) e 70 do grupo AMG (mediana de idade = 56 anos; 60 do sexo feminino). Na amostra geral, 62 pacientes (43,7%) apresentaram resultados positivos para dosagens de anticorpos IgE antitoxinas estafilocócicas: enterotoxina (TX) A, em 29 (20,4%); TXB, em 35 (24,6%); TXC, em 33 (23,2%); e toxic shock syndrome toxin (TSST), em 45 (31,7%). As médias das dosagens séricas de anticorpos IgE específicos anti-TXA, TXB, TXC e TSST foram, respectivamente, de 0,96 U/l, 1,09 U/l, 1,21 U/l, e 1,18 U/l. Não houve diferença estatisticamente significativa dos resultados qualitativos ou quantitativos entre os grupos. Conclusões: A presença de anticorpos IgE séricos anti-TXA, TXB, TXC e TSST, foi detectada em 43,7% nessa amostra de pacientes, mas não houve associação estatisticamente significativa entre seus resultados qualitativos ou quantitativos e gravidade clínica da asma.

Modo de ação do biolarvicida Lysinibacillus sphaericus: identificação do epitopo da toxina Binária no receptor Cqm1 e base molecular da seletividade / Mode of action of biolarvicide Lysinibacillus sphaericus: identification of the epitope of the CQM1 Binary toxin receptor and molecular basis of selectivity

A toxina Binária (Bin) é o principal fator tóxico da bactéria entomopatógena Lysinibacillus sphaericus e sua ação em Culex quinquefasciatus depende da ligação com receptores no intestino das larvas. Os receptores são as a-glicosidases Cqm1, localizadas no epitélio, ligadas por uma âncora de glicosil-fosfatidilinositol. Larvas de Aedes aegypti são refratárias à toxina, pois, não apresentam receptores funcionais, apesar de apresentarem um gene que codifica a proteína Aam1, com alta similaridade à Cqm1. Devido às lacunas a respeito do espectro de ação da toxina Bin, o objetivo deste estudo foi identificar epitopos de ligação da toxina no receptor Cqm1 e determinar a base molecular da sua ação para estas espécies de vetores. Os resultados obtidos a partir da análise comparativa das proteínas Cqm1 e Aam1 levaram à identificação de um epitopo da toxina Bin no receptor Cqm1, situado uma alça na região N-terminal S129-A312. Este epitopo é composto pelos aminoácidos 155PATGGG160, não conservados em Aam1 (158AETGKL163), e os resíduos 159GG160 são críticos para a ligação com a Bin...

The Bin toxin is the main toxic factor of the bacterium Lysinibacillus sphaericuswhose action in Culex quinquefasciatuslarvae depends on its binding to the midgut epithelial receptors...